A detailed history of Raymond James Trust N.A. transactions in Repligen Corp stock. As of the latest transaction made, Raymond James Trust N.A. holds 2,750 shares of RGEN stock, worth $408,375. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,750
Previous 2,275 20.88%
Holding current value
$408,375
Previous $286,000 43.01%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.79 - $167.35 $56,900 - $79,491
475 Added 20.88%
2,750 $409,000
Q2 2024

Jul 25, 2024

SELL
$120.0 - $182.95 $5,400 - $8,232
-45 Reduced 1.94%
2,275 $286,000
Q1 2024

Apr 24, 2024

BUY
$170.78 - $208.42 $55,161 - $67,319
323 Added 16.17%
2,320 $426,000
Q4 2023

Jan 10, 2024

SELL
$114.17 - $185.35 $6,621 - $10,750
-58 Reduced 2.82%
1,997 $359,000
Q3 2023

Nov 14, 2023

BUY
$138.78 - $176.51 $693 - $882
5 Added 0.24%
2,055 $326,000
Q2 2023

Aug 15, 2023

BUY
$138.42 - $180.31 $25,884 - $33,717
187 Added 10.04%
2,050 $290,000
Q1 2023

May 03, 2023

SELL
$154.26 - $198.1 $7,867 - $10,103
-51 Reduced 2.66%
1,863 $314,000
Q4 2022

Feb 02, 2023

SELL
$162.42 - $220.56 $73,901 - $100,354
-455 Reduced 19.21%
1,914 $324,000
Q3 2022

Oct 31, 2022

BUY
$160.42 - $256.21 $8,662 - $13,835
54 Added 2.33%
2,369 $444,000
Q2 2022

Jul 14, 2022

SELL
$140.68 - $188.02 $2,250 - $3,008
-16 Reduced 0.69%
2,315 $376,000
Q1 2022

May 12, 2022

BUY
$161.19 - $257.96 $102,194 - $163,546
634 Added 37.36%
2,331 $438,000
Q4 2021

Jan 31, 2022

SELL
$247.59 - $304.47 $27,977 - $34,405
-113 Reduced 6.24%
1,697 $450,000
Q3 2021

Oct 18, 2021

BUY
$194.77 - $324.21 $31,163 - $51,873
160 Added 9.7%
1,810 $523,000
Q2 2021

Jul 20, 2021

SELL
$165.87 - $220.95 $2,488 - $3,314
-15 Reduced 0.9%
1,650 $329,000
Q1 2021

May 03, 2021

BUY
$180.37 - $226.26 $100,646 - $126,253
558 Added 50.41%
1,665 $324,000
Q4 2020

Jan 13, 2021

BUY
$148.08 - $206.57 $163,924 - $228,672
1,107 New
1,107 $212,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.24B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Raymond James Trust N.A. Portfolio

Follow Raymond James Trust N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Trust N.A. with notifications on news.